Discover Research Beta

Browse peer-reviewed articles from Medwin Publishers' open access journals.

Clear Filters

Showing 1–3 of 3 articles

"Hugwil AV" ×
OAJCO Review Article Feb 26, 2021
Application of CLN-IgG/Pritumumab against COVID-19 Infectivity from the Aspect of Tumor-PIVIEMT Scheme
Hugwil AV*

The touch/tactile sensor PIEZO1/2 and vimentin network is the critical conduit for COVID-19 virus infectivity. Coordination of PIEZO1/2 and vimentin network in regard to EMT/MET w…

Anti-Cancer Antibody Human monoclonal antibody ClN-IgG/Pritumumab Idiotypic antibody
OAJCO Opinion Jun 19, 2019
Is Tumorigenesis an Abiogenesis?
Hugwil AV*

CLN-IgG (Pritumuab) was subjected to clinical trials aiming at regression of brain tumors. The mechanism underlying the dramatic recuperation of cancer patient was considered by m…

Vimentin Epitope Cancer Stem Cell Chaperonic Antibody
OAJCO Opinion Apr 9, 2018
On the Dichotomous Aspect of Cancer Stem Cell
Hugwil AV
Dichotomous Stem Cell Soncogenic